Alport syndrome registry opens doors for future therapies
NCT ID NCT00481130
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study created a registry of 655 people and families with Alport syndrome to collect health information over time. The goal is to better understand how the disease progresses and to provide a foundation for testing new treatments. Participants simply share their medical history and updates, with no experimental treatment involved.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALPORT SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug aims to plug kidney leaks in multiple diseases
- Study links gum health to rare kidney diseases
- Alport patients needed: join a registry to speed up research
- Kidney hope: drug combo may slow alport disease
- New drug aims to slow kidney damage in rare alport syndrome
- Experimental drug targets genetic cause of alport syndrome in tiny pilot